BindingDB logo
myBDB logout

BDBM304378 (R)-4-fluoro-2-(4-(4-fluoro-3-(methylsulfonyl)phenyl)-2-isopropylpiperazin-1-yl)benzo[d]thiazole::US10144715, Compound 7-54

SMILES: CC(C)[C@@H]1CN(CCN1c1nc2c(F)cccc2s1)c1ccc(F)c(c1)S(C)(=O)=O

InChI Key: InChIKey=SKGJRIXOTUPIFB-KRWDZBQOSA-N

Data: 2 KI

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 304378   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Oxysterols receptor LXR-beta


(Homo sapiens (Human))
BDBM304378
PNG
((R)-4-fluoro-2-(4-(4-fluoro-3-(methylsulfonyl)phen...)
Show SMILES CC(C)[C@@H]1CN(CCN1c1nc2c(F)cccc2s1)c1ccc(F)c(c1)S(C)(=O)=O |r|
Show InChI InChI=1S/C21H23F2N3O2S2/c1-13(2)17-12-25(14-7-8-15(22)19(11-14)30(3,27)28)9-10-26(17)21-24-20-16(23)5-4-6-18(20)29-21/h4-8,11,13,17H,9-10,12H2,1-3H3/t17-/m0/s1
UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
9n/an/an/an/an/an/an/an/a



Vitae Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds of the invention were assessed in a competition binding assay where different concentrations of compounds were incubated with the LXR ligan...


US Patent US10144715 (2018)


BindingDB Entry DOI: 10.7270/Q2PV6NFD
More data for this
Ligand-Target Pair
Oxysterols receptor LXR-alpha


(Homo sapiens (Human))
BDBM304378
PNG
((R)-4-fluoro-2-(4-(4-fluoro-3-(methylsulfonyl)phen...)
Show SMILES CC(C)[C@@H]1CN(CCN1c1nc2c(F)cccc2s1)c1ccc(F)c(c1)S(C)(=O)=O |r|
Show InChI InChI=1S/C21H23F2N3O2S2/c1-13(2)17-12-25(14-7-8-15(22)19(11-14)30(3,27)28)9-10-26(17)21-24-20-16(23)5-4-6-18(20)29-21/h4-8,11,13,17H,9-10,12H2,1-3H3/t17-/m0/s1
UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
68n/an/an/an/an/an/an/an/a



Vitae Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds of the invention were assessed in a competition binding assay where different concentrations of compounds were incubated with the LXR ligan...


US Patent US10144715 (2018)


BindingDB Entry DOI: 10.7270/Q2PV6NFD
More data for this
Ligand-Target Pair